|
|
|
|
| LEADER |
00000cam a2200000 4500 |
| 001 |
SCIDIR_on1341330031 |
| 003 |
OCoLC |
| 005 |
20231120010659.0 |
| 006 |
m o d |
| 007 |
cr un|---aucuu |
| 008 |
220819t20222022enk o 000 0 eng d |
| 040 |
|
|
|a YDX
|b eng
|c YDX
|d OPELS
|d GZM
|d N$T
|d OCLCF
|d OCLCQ
|d OCLCO
|
| 020 |
|
|
|a 9780323903646
|q (electronic bk.)
|
| 020 |
|
|
|a 0323903649
|q (electronic bk.)
|
| 020 |
|
|
|z 9780323900423
|
| 020 |
|
|
|z 0323900429
|
| 035 |
|
|
|a (OCoLC)1341330031
|
| 050 |
|
4 |
|a TP248.2
|
| 082 |
0 |
4 |
|a 660.6
|2 23
|
| 245 |
0 |
0 |
|a Biotechnology in healthcare.
|n Volume 2,
|p Applications and regulatory issues /
|c edited by Debmalya Barh.
|
| 246 |
3 |
0 |
|a Applications and regulatory issues
|
| 264 |
|
1 |
|a London, UK :
|b Academic Press,
|c [2022]
|
| 264 |
|
4 |
|c �2022
|
| 300 |
|
|
|a 1 online resource (xix, 367 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a Front Cover -- Biotechnology in Healthcare, Volume 2 -- Biotechnology in Healthcare, Volume 2: Applications and Initiatives -- Copyright -- Dedication -- Contents -- Contributors -- About editor -- Preface -- 1 -- Applications of biotechnology in healthcare -- 1 -- Biotechnology in primary healthcare and hospital management -- 1. Introduction -- 2. Primary healthcare and its importance: current status in India -- 3. Biotechnology applications in primary healthcare -- 3.1 Diagnosis -- 3.2 Treatment -- 3.3 Preventives -- 3.4 Family planning and family medicine
|
| 505 |
8 |
|
|a 4. Biotechnology in hospital management -- 4.1 Sterilization and operation theater -- 4.2 Rapid and mass molecular diagnosis -- 4.2.1 Genetic diseases, disorders, and molecular diagnosis -- 4.3 Targeted therapy -- 4.3.1 Prostate carcinoma and targeted therapy -- 4.3.2 Breast cancer and targeted therapy -- 4.3.3 Lung cancer and targeted therapy -- 4.4 Probiotic and biome replacement therapy -- 4.5 In transfusion medicine -- 5. Biotechnology-based biosafety -- 6. Challenges and future prospects -- Acknowledgments -- References -- 2 -- Biotechnology in public and rural health -- 1. Introduction
|
| 505 |
8 |
|
|a 2. Biotechnology approaches to improve public and rural health -- 2.1 Vaccines and delivery of vaccines -- 2.2 Nutrients enriched genetically modified food -- 2.3 Reduced food toxins and allergens -- 2.4 Life-saving vaccines -- 3. Advanced biotechnological achievements applied in rural areas -- 4. Environmental biotechnology applied to public and rural health -- 5. Future prospects -- References -- 3 -- Invertebrate models in translational research: lessons from Caenorhabditis elegans and Drosophila melanogaster -- 1. Introduction -- 2. Caenorhabditis elegans models for translational research
|
| 505 |
8 |
|
|a 2.1 Aging -- 2.2 Cancer -- 2.3 Rare human disease -- 2.4 Neurological and movement disorders -- 2.4.1 Alzheimer disease -- 2.4.2 Parkinson disease -- 2.4.3 Amyotrophic lateral sclerosis -- 2.5 Obesity -- 3. Drosophila models for translational research -- 3.1 Aging -- 3.2 Cancer -- 3.3 Modeling rare human diseases -- 3.4 Neurological and movement disorders -- 3.4.1 Alzheimer disease -- 3.4.2 Parkinson disease -- 3.4.3 Amyotrophic lateral sclerosis -- 3.5 Obesity -- 4. Translational impact of invertebrate research -- Glossary -- Acknowledgments -- References
|
| 505 |
8 |
|
|a 4 -- Biotechnology for diagnosis, prognosis, and monitoring cancer -- 1. Introduction -- 1.1 Limitations and advantages of tissue biopsy -- 1.2 Limitations and advantages of liquid biopsy -- 2. Types of liquid biopsy specimens -- 2.1 Circulating tumor cells -- 2.1.1 Preanalytical considerations -- 2.2 Extracellular vesicles (exosomes) -- 2.2.1 Preanalytical considerations -- 2.3 Circulating RNAs -- 2.3.1 Preanalytical considerations -- 2.4 Circulating free DNA -- 2.4.1 Preanalytical considerations -- 3. Chemical modifications to increase sensitivity in mutant detection -- 3.1 LNA-PCR -- 3.2 PNA-PCR
|
| 588 |
|
|
|a Description based on online resource; title from PDF title page (Elsevier, viewed August 31, 2022).
|
| 650 |
|
0 |
|a Biotechnology.
|
| 650 |
|
0 |
|a Medical technology.
|
| 650 |
|
6 |
|a Biotechnologie.
|0 (CaQQLa)201-0004007
|
| 650 |
|
6 |
|a Technologie m�edicale.
|0 (CaQQLa)201-0017783
|
| 650 |
|
7 |
|a bioengineering.
|2 aat
|0 (CStmoGRI)aat300250623
|
| 650 |
|
7 |
|a Biotechnology
|2 fast
|0 (OCoLC)fst00832729
|
| 650 |
|
7 |
|a Medical technology
|2 fast
|0 (OCoLC)fst01014742
|
| 700 |
1 |
|
|a Barh, Debmalya,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|z 0323900429
|z 9780323900423
|w (OCoLC)1268112036
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780323900423
|z Texto completo
|
